DEFA14A: AmpliTech Corrects Shares Outstanding for Annual Meeting

Sentiment:

Proxy Statement Supplement


AmpliTech Group, Inc. issued a supplement to its definitive proxy statement to correct a typographical error regarding the number of outstanding common shares for its upcoming annual meeting.

Summary

  • AmpliTech Group, Inc. (the Company) issued a supplement to its definitive proxy statement dated October 16, 2025.
  • The supplement corrects a typographical error in the previously stated number of shares of common stock outstanding as of the record date, October 15, 2025.
  • The incorrect number of shares was stated as 20,631,595.
  • The correct number of issued and outstanding shares as of October 15, 2025, is 20,638,095.
  • This correction does not alter the proposals for the Annual Meeting, the Record Date, or the date, time, or location of the Annual Meeting.
  • Stockholders who have already submitted proxies do not need to take further action unless they wish to change their vote.

Sentiment

Score: 5

Explanation: Neutral. The filing is a routine administrative correction of a minor typographical error, with no material impact on company operations or financial health.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Provides accurate information for voting at the Annual Meeting; no material change to their holdings or voting rights.

Next Steps

  • Hold the 2025 Annual Meeting of Stockholders on December 10, 2025.
  • Stockholders who have not yet voted should review the Proxy Statement and this Supplement before voting.

Key Dates

DateDescription
October 15, 2025Record Date for the 2025 Annual Meeting of Stockholders
October 16, 2025Original Definitive Proxy Statement filed with the SEC
December 10, 2025Date of the 2025 Annual Meeting of Stockholders

Recommendation

hold

The filing is a routine administrative correction of a typographical error in the number of shares outstanding for the upcoming annual meeting. It does not contain any information that would alter the fundamental investment thesis or warrant a change in recommendation.

Keywords

AmpliTech Group, proxy statement, shares outstanding, common stock, annual meeting, SEC filing, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.